News

Feeding wild elephants might seem kind, but a new study by researchers at the University of California San Diego warns that ...
The FDA called for Sarepta Therapeutics to stop shipping its muscular dystrophy gene therapy, but the company said no.
More than 67,000 cases of Power Stick deodorants are being recalled due to safety concerns tied to manufacturing practices, ...
It's important to stay informed about recalls, because doing so truly impacts your life. Of course, the sooner you know about ...
FDA published a press release written by FDA Commissioner Marty Makary that highlighted his efforts to “make food healthier ...
The FDA has issued a voluntary recall of over 67,000 cases of Power Stick roll-on deodorants due to deviations from ...
On July 14, 2025, the U.S. Food and Drug Administration (FDA) announced an extension to the public comment period for its ...
Supporters believe that FDA approval will make the drug more accessible. Right now, traditional psilocybin therapy offered at healing centers in the state is not covered by insurance.
Following years of legal dispute and health concerns, the U.S. Food and Drug Administration FDA finally granted approval of ...
CHICAGO - A recall is underway for tens of thousands of cases of Power Stick antiperspirant deodorant, according to the FDA; ...
Sarepta Therapeutics lays off 493 workers amid FDA probe, stock drop, and concerns over its gene therapy treatment, Elevidys.
The repeated pattern of animal abuse across multiple Fairlife suppliers points to system-wide problems in Coca-Cola's ...